Edition:
United States

Akcea Therapeutics Inc (AKCA.OQ)

AKCA.OQ on NASDAQ Stock Exchange Global Select Market

31.71USD
7 Dec 2018
Change (% chg)

-- (--)
Prev Close
$31.71
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
98,660
52-wk High
$40.60
52-wk Low
$15.24

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 19.24 -0.729
Jun '18 18.32 -0.754
Mar '18 17.11 -0.445
FY 2017 Dec '17 18.04 -0.349
Sep '17 9.91 -0.330
Jun '17 5.71 -0.705
Mar '17 6.09 -2.211
FY 2016 Dec '16 0.00 -1.171
Sep '16 0.00 -0.686
Jun '16 0.00 -0.471
Mar '16 0.00 -0.552
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 5 24.20 33.70 14.55 27.20
Quarter Ending Mar-19 4 86.96 172.30 24.70 --
Year Ending Dec-18 4 79.83 88.00 69.21 76.48
Year Ending Dec-19 5 369.92 819.00 148.40 302.27
Earnings (per share)
Quarter Ending Dec-18 5 -0.58 0.03 -0.96 -0.29
Quarter Ending Mar-19 4 -0.31 0.16 -0.69 --
Year Ending Dec-18 4 -2.53 -1.70 -3.15 -1.08
Year Ending Dec-19 4 -0.19 5.88 -2.48 0.80
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.45 30.88
P/E High - Last 5 Yrs. -- 41.60 46.69
P/E Low - Last 5 Yrs. -- 25.00 25.78
Beta -- 0.98 0.95
Price to Sales (TTM) 39.24 19.89 21.76
Price to Book (MRQ) 9.94 4.30 4.53
Price to Tangible Book (MRQ) 11.87 12.11 11.76
Price to Cash Flow (TTM) -- 21.70 22.24
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.68 1.60
Dividend Yield - 5 Year Avg -- 1.49 1.42
Dividend 5 Year Growth Rate -- -11.45 -8.76
Payout Ratio(TTM) -- 46.02 44.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 94.24 4.36 6.54
Sales (TTM) vs TTM 1 Yr. Ago 234.85 3.97 5.26
Sales - 5 Yr. Growth Rate -- 7.07 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago -121.28 22.48 22.50
EPS (TTM) vs TTM 1 Yr. Ago 48.45 -- --
EPS - 5 Yr. Growth Rate -- 6.71 7.64
Capital Spending - 5 Yr. Growth Rate -- 8.06 8.38

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.65 2.63
Current Ratio (MRQ) 3.64 3.71 3.68
LT Debt to Equity (MRQ) 0.00 7.50 9.53
Total Debt to Equity (MRQ) 0.00 10.94 13.39
Interest Coverage (TTM) -186.85 40.82 33.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 14.16 51.06 50.91
Gross Margin - 5 Yr. Avg. -- 52.20 52.22
EBITD Margin (TTM) -251.32 -- --
EBITD - 5 Yr. Avg -- 18.43 16.27
Operating Margin (TTM) -252.67 8.35 -15.11
Operating Margin - 5 Yr. Avg. -- 14.50 11.89
Pre-Tax Margin (TTM) -246.15 8.99 -13.67
Pre-Tax Margin - 5 Yr. Avg. -- 14.91 12.22
Net Profit Margin (TTM) -245.68 5.44 -17.11
Net Profit Margin - 5 Yr. Avg. -- 11.12 8.44
Effective Tax Rate (TTM) -- 21.91 21.73
Effective Tax Rate - 5 Yr. Avg. -- 23.94 24.41

Efficiency

  Company industry sector
Revenue/Employee (TTM) 727,060 989,839,630 878,349,382
Net Income/Employee (TTM) -1,786,250 115,653,467 102,474,711
Receivable Turnover (TTM) 128.00 5.43 5.49
Inventory Turnover (TTM) -- 2.74 3.99
Asset Turnover (TTM) 0.22 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -53.44 11.53 11.06
Return on Assets - 5 Yr. Avg. -- 12.44 11.85
Return on Investment (TTM) -70.82 14.34 13.80
Return on Investment - 5 Yr. Avg. -- 15.95 15.17
Return on Equity (TTM) -74.54 15.85 15.29
Return on Equity - 5 Yr. Avg. -- 16.93 16.29
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -25.88 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Akcea Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 32.59 32.61 99 93
13 Week 29.32 39.70 99 97
26 Week 28.69 29.06 99 92
52 Week 68.32 63.25 99 58
YTD 84.22 83.63 99 65
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 26.32%
# of Holders: 106
Total Shares Held: 23,477,857
3 Mo. Net Change: 538,550
# New Positions: 23
# Closed Positions: 11
# Increased Positions: 50
# Reduced Positions: 40
# Net Buyers: 10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.